Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Vaccine ; 41(3): 649-656, 2023 01 16.
Article in English | MEDLINE | ID: mdl-36526507

ABSTRACT

Research suggest prenatal vaccination against coronavirus disease-19 (COVID-19) is safe. However, previous studies utilized retrospectively collected data or examined late pregnancy vaccinations. We investigated the associations of COVID-19 vaccination throughout pregnancy with delivery and neonatal outcomes. We included 1,794 mother-neonate dyads enrolled in the Generation C Study with known prenatal COVID-19 vaccination status and complete covariate and outcome data. We used multivariable quantile regressions to estimate the effect of prenatal COVID-19 vaccination on birthweight, delivery gestational age, and blood loss at delivery; and Poisson generalized linear models for Caesarean delivery (CD) and Neonatal Intensive Care Unit (NICU) admission. Using the above methods, we estimated effects of trimester of vaccine initiation on these outcomes. In our sample, 13.7% (n = 250) received at least one prenatal dose of any COVID-19 vaccine. Vaccination was not associated with birthweight (ß = 12.42 g [-90.5, 114.8]), gestational age (ß = 0.2 days [-1.1, 1.5]), blood loss (ß = -50.6 ml [-107.0, 5.8]), the risks of CD (RR = 0.8; [0.6, 1.1]) or NICU admission (RR = 0.9 [0.5, 1.7]). Trimester of vaccine initiation was also not associated with these outcomes. Our findings suggest that there is no associated risk between prenatal COVID-19 vaccination and adverse delivery and neonatal outcomes in a cohort sample from NYC.


Subject(s)
COVID-19 Vaccines , COVID-19 , Pregnancy Outcome , Female , Humans , Infant, Newborn , Pregnancy , Birth Weight , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , New York City/epidemiology , Retrospective Studies
2.
Matern Child Health J ; 24(7): 845-855, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32347439

ABSTRACT

INTRODUCTION: Implementation of community-based healthcare services offering effective contraception, antenatal care (ANC), and treatment for symptomatic children under five has reduced maternal and child mortality in Togo. However, understanding if women are utilizing these services differentially based on social or demographic factors is important. This study identifies whether sexual relationship and socio-demographic factors are associated with healthcare utilization in four health facility catchment areas. METHODS: We conducted a cross-sectional household survey of women aged 15-49 in four health facility catchment areas in 2016 (three rural sites, one urban site). We used multivariable Poisson regression to test whether socio-demographic factors and a validated sexual relationship power scale were associated with contraceptive use, ANC visits, and seeking treatment for symptomatic children under five. RESULTS: Among women not pregnant or desiring pregnancy, older age, lower education, and single relationship status were associated with lower use of effective contraception. Among women who gave birth in two years preceding survey, low relationship power and low wealth quintile were associated with being less likely to attend at least four ANC visits. Women in rural sites were slightly more likely than women in the urban site to report seeking treatment for child under five with malaria, pneumonia, and/or diarrhea symptoms in last 2 weeks. DISCUSSION: Interventions in low-resource settings should explore ways to reach women with low health-service utilization to improve contraceptive use, ANC visits, and treatment for sick children. Furthermore, age, education, marital status, wealth status and sexual relationship power must be considered when targeting maternal health behaviors. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03773913; Date of registration: 12 Dec. 2018.


Subject(s)
Contraception Behavior/statistics & numerical data , Prenatal Care/statistics & numerical data , Sexual Behavior/psychology , Socioeconomic Factors , Adolescent , Adult , Child , Child Care/methods , Child Care/statistics & numerical data , Contraception Behavior/psychology , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Patient Acceptance of Health Care/statistics & numerical data , Pregnancy , Prenatal Care/methods , Prenatal Care/trends , Sick Leave/statistics & numerical data , Surveys and Questionnaires , Togo
3.
Arthritis Care Res (Hoboken) ; 70(2): 230-235, 2018 02.
Article in English | MEDLINE | ID: mdl-28480528

ABSTRACT

OBJECTIVE: We examined rates of adverse pregnancy outcomes (APO) by race/ethnicity among women with systemic lupus erythematosus (SLE), with and without antiphospholipid antibodies (aPL), and whether socioeconomic status (SES) accounted for differences. METHODS: Data were from the PROMISSE (Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus) study, a multicenter study that enrolled 346 patients with SLE and 62 patients with SLE and aPL (50% white, 20% African American, 17% Hispanic, 12% Asian/Pacific Islander). Measures of SES were educational attainment, median community income, and community education. Logistic regression analyses were conducted to determine odds of APO for each racial/ethnic group, controlling first for age and clinical variables, and then for SES. RESULTS: The frequency of APO in white women with SLE, with and without aPL, was 29% and 11%, respectively. For African American and Hispanic women it was approximately 2-fold greater. In African American women with SLE alone, adjustment for clinical variables attenuated the odds ratio (OR) from 2.7 (95% confidence interval [95% CI] 1.3-5.5) to 2.3 (95% CI 1.1-5.1), and after additional adjustment for SES, there were no longer significant differences in APO compared to whites. In contrast, in SLE patients with aPL, whites, African Americans, and Hispanics had markedly higher risks of APO compared to white SLE patients without aPL (OR 3.5 [95% CI 1.4-7.7], OR 12.4 [95% CI 1.9-79.8], and OR 10.4 [95% CI 2.5-42.4], respectively), which were not accounted for by clinical or SES covariates. CONCLUSION: This finding suggests that for African American women with SLE without aPL, SES factors are key contributors to disparities in APO, despite monthly care from experts, whereas other factors contribute to disparities in SLE with aPL.


Subject(s)
Asian , Black or African American , Health Status Disparities , Hispanic or Latino , Lupus Erythematosus, Systemic/ethnology , Pregnancy Complications/ethnology , Socioeconomic Factors , White People , Adult , Antibodies, Antiphospholipid/blood , Biomarkers/blood , Female , Humans , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/diagnosis , Pregnancy , Pregnancy Complications/blood , Pregnancy Complications/diagnosis , Pregnancy Outcome/ethnology , Risk Factors , United States/epidemiology , Young Adult
4.
Psychoneuroendocrinology ; 38(4): 592-6, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22917621

ABSTRACT

OBJECTIVE: To examine stress-induced corticosterone responses and forebrain glucocorticoid receptor (GR) levels in prepubertal and adult, male and female mice of three commonly used inbred (C57BL/6, BALB/c) and outbred (Swiss Webster) strains. METHODS: Prepubertal (30 days of age) and adult (75 days of age), male and female C57BL/6, BALB/c, and Swiss Webster mice were exposed to a 30 min session of restraint stress. Plasma corticosterone was measured before (basal), or 0, 30, or 60 min after termination of the stressor. GR protein levels of the medial prefrontal cortex, paraventricular nucleus of the hypothalamus, and hippocampus were also measured via tissue punches and western blots in the prepubertal and adult males and females at the basal time point. RESULTS: In response to acute stress, prepubertal males of both inbred strains showed greater hormonal responsiveness than their adult counterparts, while females of these strains displayed similar stress-induced corticosterone responses, independent of age. Conversely, only the females of the outbred Swiss Webster strain showed pubertal-related changes, with adult females showing greater hormonal reactivity compared to prepubertal females. Despite these significant differences in hormonal reactivity, we found little difference in GR protein levels in the brain regions examined. CONCLUSIONS: These data indicate that pubertal-dependent differences in stress reactivity can be significantly influenced by sex and genetic background. Moreover, these data provide points of departure for future studies investigating how puberty, sex, and genetic background interact to shape both short- and long-term effects of stress on mental and physical health.


Subject(s)
Prosencephalon/metabolism , Receptors, Glucocorticoid/metabolism , Restraint, Physical/physiology , Sexual Maturation/physiology , Stress, Physiological/physiology , Animals , Animals, Outbred Strains , Corticosterone/blood , Female , Male , Mice , Mice, Inbred Strains , Sex Characteristics , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...